2003 Year in Review - PowerPoint PPT Presentation

1 / 22
About This Presentation
Title:

2003 Year in Review

Description:

Karissa Luckett, RN, BSN, MSW, AE-C. Director Disease Management & Wellness, ... NACHRI as JCAHO ORYX Core Measure Performance Measurement System (PMS) ... – PowerPoint PPT presentation

Number of Views:31
Avg rating:3.0/5.0
Slides: 23
Provided by: JSP9
Category:
Tags: oryx | review | year

less

Transcript and Presenter's Notes

Title: 2003 Year in Review


1
Can the Joint Commission improve Asthma Care
Quality? (A review of Core Measures, and
Disease-Specific Certification Implications)Kari
ssa Luckett, RN, BSN, MSW, AE-CDirector Disease
Management Wellness, Childrens Medical
CenterPresident, Asthma Coalition of Texas
2
Childrens Asthma Care Core Measures
  • Core measures fall under the Joint Commissions
    Specifications for National Hospital Quality
    Measures, released December 1st, 2006 for
    implementation with April 1st, 2007 Discharges
  • CAC-1 Relievers administered, if not
    contraindication documented
  • CAC-2 Systemic corticosteroids administered, if
    not contraindication documented
  • CAC-3 Home Management Plan of Care (HMPC)
    Document Given to Patient/Caregiver

3
Special Notes
  • The initial CAC measure set is comprised of 3
    performance measures.
  • CAC-1 and CAC-2 are NQF endorsed and on the HQA
    implementations agenda.
  • CAC-3 is currently pending NQF review and
    endorsement, and is therefore implemented as a
    test measure.
  • Release Notes available at
  • http//www.jointcommission.org/PerformanceMeasure
    ment/Performance Measurement/ChildrensAsthmaCare
    (CAC)PerformanceMeasureSet. htm

4
NACHRI as JCAHO ORYX Core Measure Performance
Measurement System (PMS)
  • Announced January 11, 2007
  • NACHRI was part of the CAC development through
    involvement in the Pedi-QS collaborative
  • This enables participating childrens hospitals
    to collect and report all their JCAHO quality
    measures through NACHRI s Performance
    Measurement System (PMS)
  • Collaborative with Quantros to provide a
    web-based data repository that will aid in
    reporting, age stratification and selection of
    charts for manual review.
  • For additional information visit
    http//www.childrenshospitals.net/AM/Template.cfm?
    SectionSearch template/CM/HTMLDisplay.cfmConte
    ntID24362

5
CAC-1 Relievers
  • Rationale The use of relievers is a widely
    accepted practice in treating acute asthma
    exacerbations.
  • Changes from 2006- administered added to
    numerator definition change in method of data
    pull.
  • Measure Sub-groups
  • CAC-1a Relievers for Inpatient Asthma Overall
    (Ages 2-17)
  • CAC-1b Relievers for Inpatient Asthma (Ages 2-4)
  • CAC-1b Relievers for Inpatient Asthma (Ages
    5-12)
  • CAC-1b Relievers for Inpatient Asthma (Ages
    13-17)

6
CAC-2 Systemic Corticosteroids
  • Rationale The use of systemic corticosteroids
    has a been a recommendation in treating acute
    asthma exacerbations.
  • by the NHLBIs National Asthma Expert Prevention
    Panel (NAEPP) since 1997.
  • Changes from 2006- administered added to
    numerator definition change in method of data
    pull.
  • Measure Sub-groups
  • CAC-1a Systemic Corticosteroids for Inpatient
    Asthma Overall (Ages 2-17)
  • CAC-1b Systemic Corticosteroids for Inpatient
    Asthma (Ages 2-4)
  • CAC-1b Systemic Corticosteroids for Inpatient
    Asthma (Ages 5-12)
  • CAC-1b Systemic Corticosteroids for Inpatient
    Asthma (Ages 13-17)

7
CAC-3 Home Management Plan of Care
  • Rationale It has long been a recommendation by
    the NAEPP that patients receive a written plan of
    care (action plan).
  • The HMPC is a combination of the action plan, and
    traditional hospital discharge forms.
  • Measure Elements (7)
  • HMPC document given to patient/caregiver
  • HMPC document present (on chart)
  • HMPC document addresses appointment for
    follow-up care
  • HMPC document addresses environmental control
    and control of triggers
  • HMPC document addresses methods and timing of
    rescue medications
  • HMPC document addresses use of relievers
  • HMPC document addresses use of controllers

8
The Old Action Plan
9
The New Home Management Plan of Care
10
Implications of CAC
  • New HMPC has more of an acute care focus
  • Help drive more appropriate patient follow-up
    care (Will force hospitals to engage primary
    care providers or create own clinics, with 24/7
    scheduling capabilities)
  • Refined measure definitions provides more
    meaningful data (CAC-1 and CAC-2)
  • Movement away from traditional action plan, may
    force hand of primary care providers to take
    greater ownership
  • Creates greater opportunity with Managed Care to
    coordinate care across continuum

11
CAC Concerns
  • Competing priorities When a patient is admitted
    after hours, will hospital schedule an
    appointment with provider within their system or
    recommend patient call and schedule appointment
    with normal provider after discharge?
  • Does mixing the traditional action plan, with a
    discharge instruction sheet create information
    overload?
  • Will the more robust medication measure influence
    physician prescribing behavior?

12
CAC Concerns
  • Labor intensive nature of data collection for
    CAC-3. Will pediatric hospitals invest the
    resources to submit meaningful data?
  • If we see a rise in Asthma Education clinics
    and/or Disease Management programs to meet CAC-3
    discharge follow-up element, how will we regulate
    quality of programs? Will these services be
    reimbursed?

13
Assessing the Quality of Disease Management
Programs
  • External Validation of Quality
  • Joint Commission Disease-Specific Care
    Certification
  • NCQA Disease Management Accreditation
  • Nationally recognized evaluation focused on
  • Compliance with consensus-based national
    standards
  • Effective use of evidence-based clinical practice
    guidelines
  • Organized approach to performance improvement
    activities

14
What is Disease-Specific Care Certification?
  • Voluntary evaluation of disease management and
    chronic care programs based on
  • Evidence of compliance with D-SC performance
    elements
  • Clinical Care
  • Self-Management
  • Information Management
  • Performance Measurement
  • Program Management
  • Two Year certification
  • One year certification awarded after a successful
    site review
  • Additional one-year extension granted, contingent
    on continued compliance with standards and
    regular submission of performance measurement
    data to the Joint Commission
  • For information http//www.jointcommission.or
    g/CertificationPrograms/Disease-SpecificCare/

15
Certification vs.
Accreditation
  • Unannounced Survey
  • Organization-based
  • Focused on quality, safe care, process and
    function
  • Assess compliance with NPSG
  • Pre-defined Accreditation Services (Hospital,
    Home Care, Long Term Care, etc.)
  • 5 Day Short Notice before review
  • Service-based
  • Focused on quality, outcomes, and improving
    clinical care
  • Assess compliance with NPSG as appropriate to
    service
  • Voluntary, not an add on to accreditation
  • Review consultative in nature
  • Any condition meeting eligibility requirements
    can be certified

16
Facts about Disease-Specific Certification
  • In the US
  • - 418 Organizations with certification
  • - 578 certified programs
  • - 2 National Providers Programs
  • - 11 Certified Asthma Programs, of that 4
    pediatric
  • In Texas
  • - 23 Organizations with certification
  • - 28 certified programs (3 organizations hold
    multiple)
  • - 1 Certified Asthma Program (Childrens
    Medical Center, Dallas)

17
Performance Measurement
  • Certified Programs must declare use of National
    Guidelines, or develop own that meet the
    requirements of National Guideline Clearinghouse
    (http//www.guideline.gov/)
  • Stage I Non-standardized Measures Programs are
    required to collect and analyze data on 4 or more
    performance measures.   The Joint Commission is
    not prescriptive regarding the specific measures.
  • Stage II Standardized Measures Standardized sets
    of measures are identified and specified by The
    Joint Commission and external performance
    measurement experts. Currently, standardized
    measures are available for Primary Stroke Center
    certification, LVR, VAD, and Inpatient Diabetes.

18
Stage I Performance Measurement - Detail
  • Explicit operational definitions
  • for numerator and denominator
  • required for application.
  • Monthly data points on
  • quarterly submission.
  • 4 months, or one quarter
  • data now required with initial
  • application.
  • Measures categories Clinical,
    Administrative/Financial, Health Status,
    Perception of Care/Services.
  • New requirements for 2007

19
Process Improvement Plan Requirements
  • Quarterly PI plan documentation that relates to
    Program Measures, or other relevant issues.
  • Staff must be able to articulate program PI Plan
    and measures.
  • Plan should be fluid document, with regular
    updates in progress and measures.

20
Lessons Learned at Childrens Dallas
  • Pursuit of Joint Commission Certification
  • Unified approach to Performance measurement and
    Process Improvement planning
  • Prioritized evidence-based approach
  • Standardized approach to Disease management
    across various programs
  • Strengthened contracting potential
  • Solidified marketing message
  • Application process facilitated teambuilding
    among programs

21
For more Information on Disease-Specific Care
Certification
  • Disease-Specific Care Certification Workshops
  • Discussion of DSC requirements
  • Description of the elements of a good measure
  • Explanation for completing the Measurement
    Information form
  • Demonstration of how DSC Certification enhances
    patient care
  • 2008 Disease-Specific Care Certification Manual
  • 2008 Disease-Specific Care Fall Conference
  • Build a business case using the employer
    perspective
  • Assess information from organizational case study
  • Integrate current theories of disease
    self-management
  • Evaluate useful performance measures
  • For additional information visit
    http//www.jcrinc.com

22
If you have additional Questions,Please feel
free to contact Karissa at214-456-8456orKarissa
.Luckett_at_childrens.com
Write a Comment
User Comments (0)
About PowerShow.com